ContextPrescription drugs are instrumental to managing and preventing chronic disease.
Recent changes in US prescription drug cost sharing could affect access to them …

Generic drugs have a key role to play in the efficient allocation of financial resources for
pharmaceutical medicines. Policies implemented in the countries with a high rate of generic …

Medical practice in the United States has changed dramatically in the last several decades,
especially with more frequent use of prescription drugs. A higher volume and better-quality …

Rising prices of medicines are putting them beyond the reach of many people, even in rich
countries. In less-developed countries, millions of individuals do not have access to …

Rising pharmaceutical expenditures have led to the use of cost-sharing measures. The
authors undertook a systematic review of the effects of cost sharing on vulnerable …

In recent years health insurers have placed a great deal of emphasis on the ability of generic
medicines to deliver significant savings to overstretched health care budgets due to their …

As pharmaceutical expenditure continues to rise, third-party payers in most high-income
countries have increasingly shifted the burden of payment for prescription drugs to patients …

Background Pharmaceuticals are important interventions that could improve people's health.
Pharmaceutical pricing and purchasing policies are used as cost‐containment measures to …

States are reacting to increased Medicaid drug costs by implementing cost-control policies,
such as preferred drug lists (PDLs) and prior authorization. PDLs have risks as well as …

Background—As medication spending grows, Medicare Part D will need to adapt its
coverage policies according to emerging evidence from a variety of insurance policies. We …